CRMAX
Price
$12.26
Change
-$0.15 (-1.21%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CRMAX vs VIMSX

Header iconCRMAX vs VIMSX Comparison
Open Charts CRMAX vs VIMSXBanner chart's image
CRM Small/Mid Cap Value I
Price$12.26
Change-$0.15 (-1.21%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CRMAX vs VIMSX Comparison Chart
Loading...
VS
CRMAX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a StrongBuy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. CRMAX (175M). VIMSX pays higher dividends than CRMAX: VIMSX (1.38) vs CRMAX (0.59). CRMAX was incepted earlier than VIMSX: CRMAX (20 years) vs VIMSX (26 years). CRMAX is a more actively managed with annual turnover of: 42.00 vs. VIMSX (13.00). CRMAX has a lower initial minimum investment than VIMSX: CRMAX (2500) vs VIMSX (3000). CRMAX (26.34) and VIMSX (25.11) have marching annual gain over last year. VIMSX return over 5 years is better than : 56.75 vs. CRMAX (9.85).
CRMAXVIMSXCRMAX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years26 years-
Gain YTD15.44312.557123%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets175M172B0%
Annual Yield % from dividends0.591.3843%
Returns for 1 year26.3425.11105%
Returns for 3 years-13.579.82-138%
Returns for 5 years9.8556.7517%
Returns for 10 years-28.66128.21-22%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma